At a time when many big-ticket GPs are buying up specialist life science investors, France-based Jeito Capital is focused on staying an independent investor as it gears up to deploy the remaining third of its EUR 534m debut fund, founder Rafaèle Tordjman tells Unquote.
French sponsor seeks to attract state-backed LPs for new strategy targeting ESG-focused startups
Director appointments include Rutland Partners' Matt Hamilton-Allen, who joins the investment team
New vehicle exceeded target by more than USD 300m; aims for up to 20% exposure to European debt
New vehicle will invest at the crossover of health care, life sciences and tech with EUR 5m-50m tickets